TSE:TH Theratechnologies - TH News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$1.17 +0.01 (+0.86%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's RangeC$1.14▼C$1.1750-Day RangeC$1.00▼C$1.4052-Week RangeC$1.00▼C$3.75Volume1,800 shsAverage Volume25,270 shsMarket CapitalizationC$113.27 millionP/E RatioN/ADividend YieldN/APrice TargetC$3.25 ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TH and its competitors with MarketBeat's FREE daily newsletter. Email Address TH Media Mentions By Week TH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TH News Sentiment▼0.560.63▲Average Medical News Sentiment TH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TH Articles This Week▼01▲TH Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTheratechnologies (TSE:TH) Hits New 52-Week Low at $1.00americanbankingnews.com - March 15 at 9:36 AMTheratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Modelfinance.yahoo.com - March 14 at 7:23 PMTheratechnologies Full Year 2022 Earnings: EPS Misses Expectationsfinance.yahoo.com - March 2 at 10:04 AMTheratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022finance.yahoo.com - February 28 at 8:46 AMTheratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIVfinance.yahoo.com - February 22 at 10:18 PMStocks in play: Theratechnologies Inc.ca.finance.yahoo.com - February 18 at 7:16 AMTheratechnologies Announces Path to Resume TH1902 Clinical Developmentfinance.yahoo.com - February 16 at 7:48 AMTheratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Updatefinance.yahoo.com - February 14 at 6:53 PMTheratechnologies Inc. (THTX) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - February 10 at 6:42 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED) and Mainz Biomed B.V. (MYNZ)markets.businessinsider.com - February 9 at 5:16 PMTheratechnologies: Top 10 Undervalued Healthcare Sector Stocks on TSX (TH)theglobeandmail.com - February 8 at 1:49 AMHIV Market 2023 : Advance Technology, Latest Trend and Future Expansion by 2028marketwatch.com - January 23 at 10:52 AMGlobal HIV Antiretroviral Drug Market 2023 Size and Growth Analysis by Manufacture, Type, Application, Market Dynamic and Forecast to 2028marketwatch.com - January 10 at 9:51 AMOpen Letter to Shareholders from CEO Paul Levesquefinance.yahoo.com - January 4 at 10:10 AMShareholders in Theratechnologies (TSE:TH) are in the red if they invested five years agofinance.yahoo.com - December 23 at 3:17 PMTheratechnologies Announces Update from Ongoing TH1902 Studyfinance.yahoo.com - December 1 at 7:51 PMTheratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarraysfinance.yahoo.com - October 26 at 9:17 AMForm 6-K Theratechnologies Inc. For: Oct 13 - StreetInsider.comstreetinsider.com - October 13 at 8:50 AMTheratechnologies Inc. Tops Q3 EPS by 4c By Investing.com - Investing.cominvesting.com - October 13 at 8:50 AMTheratechnologies: Q3 Earnings Insights - Theratechnologies (NASDAQ:THTX) - Benzingabenzinga.com - October 13 at 8:50 AMTheratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update - GlobeNewswireglobenewswire.com - October 13 at 8:50 AMTheratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Updatefinance.yahoo.com - October 13 at 8:50 AMEarnings Preview: Theratechnologies - Theratechnologies (NASDAQ:THTX) - Benzingabenzinga.com - October 12 at 10:49 PMTheratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium - GlobeNewswireglobenewswire.com - October 12 at 7:47 AMTheratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposiumfinance.yahoo.com - October 12 at 7:47 AMPre-market Movers: FNGR, AERC, FAZE, ARC, ADEA… - Nasdaqnasdaq.com - October 4 at 7:00 PMWhy AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket By Benzinga - Investing.com UKuk.investing.com - October 4 at 7:00 PMFaZe Holdings, KalVista Pharmaceuticals, Theratechnologies among premarket losers' pack - Seeking Alphaseekingalpha.com - October 4 at 8:59 AMTheratechnologies shares are trading higher after the company announced FDA approval of Trogarzo for admi - Benzingabenzinga.com - October 3 at 3:59 PMTheratechnologies' Trogarzo Approved By FDA For 30-Second Intravenous (IV) Push, Simplifying HIV Treatment For Heavily Treatment-Experienced Population - Theratechnologies (NASDAQ:THTX) - Benzingabenzinga.com - October 3 at 3:59 PMTheratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Populationfinance.yahoo.com - October 3 at 3:59 PMTheratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update - Yahoo Financefinance.yahoo.com - September 26 at 4:29 PMTheratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Updatefinance.yahoo.com - September 26 at 11:28 AMTheratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growthfinance.yahoo.com - September 12 at 8:17 AMHIV Market 2022, Gross Margin, Market Competitive Situation and Trends, Market Share of Top Players, Mergers and Acquisitions, Expansion by 2029marketwatch.com - August 23 at 12:22 AMTheratechnologies (THTX) Investor Presentation - Slideshowseekingalpha.com - August 19 at 10:18 PMTheratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Regimensfinance.yahoo.com - July 28 at 2:23 PMForm 6-K/A Theratechnologies Inc. For: Jul 20 - StreetInsider.comstreetinsider.com - July 20 at 3:59 PMTheratechnologies (TSE:TH) investors are sitting on a loss of 62% if they invested five years agofinance.yahoo.com - July 16 at 3:37 PMTheratechnologies Stock Jumps After Q2 Earnings, FY22 Guidancefinance.yahoo.com - July 14 at 6:53 PMTheratechnologies stock gains on securing $100M term loan (NASDAQ:THTX) - Seeking Alphaseekingalpha.com - July 14 at 1:53 PMTheratechnologies revenue of $19.27M misses by $0.86M, tightens FY2022 revenue outlook - Seeking Alphaseekingalpha.com - July 14 at 8:50 AMTheratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update - GlobeNewswireglobenewswire.com - July 14 at 8:50 AMTheratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designated TH1902 First-in-Human Study in Advanced Resistant Malignancies - GlobeNewswireglobenewswire.com - July 14 at 8:50 AMTheratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designated TH1902 First-in-Human Study in Advanced Resistant Malignanciesfinance.yahoo.com - July 14 at 8:50 AMTheratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Updatefinance.yahoo.com - July 14 at 8:50 AMCQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréalfinance.yahoo.com - July 12 at 8:55 AMTheratechnologies to Announce Second Quarter 2022 Financial Results and Provide Business Update - GlobeNewswireglobenewswire.com - July 7 at 7:51 AMTheratechnologies to Announce Second Quarter 2022 Financial Results and Provide Business Updatefinance.yahoo.com - July 7 at 7:51 AMTheratechnologies Announces New Head of Investor Relations - Yahoo Financefinance.yahoo.com - May 31 at 5:15 PM Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TH and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (TSE:TH) was last updated on 3/25/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.